DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 67 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $127,000 | -93.5% | 44,002 | -86.8% | 0.00% | – |
| Q3 2016 | $1,967,000 | +107.7% | 334,603 | +6.0% | 0.00% | – |
| Q2 2016 | $947,000 | -72.8% | 315,722 | -51.5% | 0.00% | -100.0% |
| Q1 2016 | $3,488,000 | -54.5% | 650,704 | +0.8% | 0.00% | -50.0% |
| Q4 2015 | $7,662,000 | +137.7% | 645,510 | +64.4% | 0.00% | +100.0% |
| Q3 2015 | $3,224,000 | -41.8% | 392,716 | -1.1% | 0.00% | 0.0% |
| Q2 2015 | $5,541,000 | +119.6% | 397,184 | +278.3% | 0.00% | 0.0% |
| Q1 2015 | $2,523,000 | +48.5% | 104,989 | +1.7% | 0.00% | – |
| Q4 2014 | $1,699,000 | +50.9% | 103,184 | +16.6% | 0.00% | – |
| Q3 2014 | $1,126,000 | -43.2% | 88,469 | +0.6% | 0.00% | -100.0% |
| Q2 2014 | $1,984,000 | -27.3% | 87,901 | -9.0% | 0.00% | 0.0% |
| Q1 2014 | $2,730,000 | – | 96,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $89,888,000 | 13.40% |
| EcoR1 Capital, LLC | 3,627,597 | $79,916,000 | 7.20% |
| Aquilo Capital Management, LLC | 614,436 | $13,536,000 | 5.08% |
| RTW INVESTMENTS, LP | 5,874,229 | $129,409,000 | 4.88% |
| BRIDGER MANAGEMENT, LLC | 1,981,633 | $43,655,000 | 3.15% |
| ACUTA CAPITAL PARTNERS, LLC | 387,500 | $8,537,000 | 2.11% |
| Integral Health Asset Management, LLC | 200,000 | $4,406,000 | 1.72% |
| Burrage Capital Management LLC | 104,047 | $2,292,000 | 1.54% |
| Parkman Healthcare Partners LLC | 240,000 | $5,287,000 | 1.53% |
| EAM Global Investors LLC | 122,237 | $2,693,000 | 1.08% |